TYRANasdaqPharmaceutical PreparationsFiscal year ends December 31
Tyra Biosciences, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 4, 2026
$19.34+0.82 (+4.43%)
Close on Oct 19, 2026
- Market cap
- $1.28B
- P/E (TTM)
- –
- Dividend yield
- –
Fundamental chart
Pick a measure to chart its full history
-$132.76MFY2025